Lewis Asset Management’s AbbVie ABBV Stock Holding History

Lewis Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.08M	Buy	16,195 +2,606	+19%	+$561K	1.43%	14
2026 Q1	$2.96M	Buy	13,589 +1,877	+16%	+$416K	1.21%	20
2025 Q4	$2.68M	Sell	11,712 -272	-2%	-$62K	1.09%	21
2025 Q3	$2.77M	Buy	11,984 +74	+0.6%	+$15.1K	1.14%	19
2025 Q2	$2.21M	Buy	11,910 +923	+8%	+$172K	1.04%	23
2025 Q1	$2.3M	Buy	10,987 +50	+0.5%	+$9.72K	1.9%	11
2024 Q4	$1.94M	Buy	10,937 +250	+2%	+$46K	1.48%	15
2024 Q3	$2.11M	Buy	10,687 +354	+3%	+$66.1K	1.54%	13
2024 Q2	$1.77M	Buy	10,333 +168	+2%	+$27.8K	1.35%	15
2024 Q1	$1.85M	Sell	10,165 -776	-7%	-$134K	1.52%	17
2023 Q4	$1.7M	Buy	+10,941	New	+$1.6M	1.56%	15

Other funds holding ABBV

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Lewis Asset Management's ABBV Position: Q2 2026 in Review

Lewis Asset Management increased its AbbVie (ABBV) stake by 19% in Q2 2026, buying an estimated $561K and bringing the position to 16,195 shares worth $4.08M. The position accounts for 1.43% of the portfolio, ranked #14.

Lewis Asset Management first reported a position in ABBV in Q4 2023 and has held it in 11 quarters since. 2,013 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Lewis Asset Management held 16,195 shares of AbbVie worth $4.08M as of Q2 2026.
Lewis Asset Management bought 2,606 AbbVie shares in Q2 2026, an estimated $561K.
AbbVie made up 1.43% of Lewis Asset Management's portfolio in Q2 2026, its #14 holding.
Lewis Asset Management first reported a position in AbbVie in Q4 2023 and has held it in 11 quarters since.
2,013 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Lewis Asset Management's 13F filing for Q2 2026, filed 21 Jul 2026.